Hua-Ling Tsai

Johns Hopkins University — United States

Medicine · Health Sciences

25h-index2.7kcitations53works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(13), Acute Myeloid Leukemia Research(7), Acute Lymphoblastic Leukemia research(7), Thyroid Cancer Diagnosis and Treatment(5), Lymphoma Diagnosis and Treatment(4)

Publications53 total

Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing
JCO Oncology Practice·2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
Leukemia & lymphoma/Leukemia and lymphoma·2026
Post-allogeneic hematopoietic cell transplantation outcomes are similar after hypomethylating agent/venetoclax and intensive, cytarabine-based remission induction for Acute Myeloid Leukemia when using standardized, contemporary transplant techniques
Blood·2025Open Access
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis
PLoS Pathogens·2025· 2 citedOpen Access
Patterns of recurrence after curative intent hepatic resection for colorectal liver metastasis
Journal of Gastrointestinal Surgery·2024· 6 cited
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer
PLoS ONE·2024· 1 citedOpen Access
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System Lymphoma
Transplantation and Cellular Therapy·2021· 7 citedOpen Access
Large Granular Lymphocytosis With Cytopenias After Allogeneic Blood or Marrow Transplantation: Clinical Characteristics and Response to Immunosuppressive Therapy
Transplantation and Cellular Therapy·2020· 6 cited
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
Cell Reports Medicine·2020· 78 citedOpen Access
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
Blood Advances·2020· 30 citedOpen Access
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Biology of Blood and Marrow Transplantation·2020· 10 citedOpen Access
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia
Biology of Blood and Marrow Transplantation·2019· 15 citedOpen Access
Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70
Blood Advances·2019· 29 citedOpen Access
The Significance of Ascites in Patients With Pancreatic Ductal Adenocarcinoma
Pancreas·2019· 17 citedOpen Access
R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma
Leukemia & lymphoma/Leukemia and lymphoma·2019· 20 citedOpen Access
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
Biology of Blood and Marrow Transplantation·2018· 49 citedOpen Access
The prognostic impact of pathologic lymph nodes in HPV-positive oropharyngeal cancers
Oral Oncology·2018· 7 cited
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes
Biology of Blood and Marrow Transplantation·2018· 40 citedOpen Access
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide
Biology of Blood and Marrow Transplantation·2017· 78 citedOpen Access
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
Leukemia Research·2017· 11 cited
page 1 of 3Next →

Frequent Co-authors

Richard J. Jones(20), Richard F. Ambinder(16), Jeanne Kowalski(16), Douglas E. Gladstone(15), Lode J. Swinnen(15), Ephraim J. Fuchs(15), Javier Bolaños‐Meade(14), Carol Ann Huff(13), Ivan Borrello(13), Robert A. Brodsky(11), Leo Luznik(11), Margaret M. Showel(10), William Matsui(10), B. Douglas Smith(10), Yvette L. Kasamon(9), Ravi Varadhan(9), Gary L. Rosner(8), Keith W. Pratz(8), Ivana Gojo(8), Amy E. DeZern(7)